Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease

Summary

RATIONALE: Fludarabine may be an effective treatment for graft-versus-host disease caused by bone marrow transplantation. PURPOSE: Phase I/II trial to study the effectiveness of fludarabine in treating patients who have chronic graft-versus-host disease that has not responded to steroid therapy.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications